exai bio
@exai.bio
cfRNA + AI for next-generation liquid biopsy (https://exai.bio)
Yesterday our co-founder and CSO @babak-a.bsky.social presented at the Biotech-Pharma Statistics Workshop (BBSW) about the powerful combination of AI and cell-free RNA to detect early-stage lung cancer in the blood.
November 7, 2025 at 5:04 PM
Yesterday our co-founder and CSO @babak-a.bsky.social presented at the Biotech-Pharma Statistics Workshop (BBSW) about the powerful combination of AI and cell-free RNA to detect early-stage lung cancer in the blood.
Reflecting on a productive week of meetings at ASCO! Thank you to all those who visited our Innovation Hub booth to learn more about our technology. #ASCO25 #LiquidBiopsy #AI #RNA
June 6, 2025 at 6:25 PM
Reflecting on a productive week of meetings at ASCO! Thank you to all those who visited our Innovation Hub booth to learn more about our technology. #ASCO25 #LiquidBiopsy #AI #RNA
Congratulations to our Board Director Karen Knudsen MBA PhD for receiving the 2025 Allen Lichter Visionary Leader Award from American Society of Clinical Oncology (ASCO). We are so grateful for your leadership, passion and the profound impact you have on the cancer community. #ASCO25 #Leadership
June 2, 2025 at 7:58 PM
Congratulations to our Board Director Karen Knudsen MBA PhD for receiving the 2025 Allen Lichter Visionary Leader Award from American Society of Clinical Oncology (ASCO). We are so grateful for your leadership, passion and the profound impact you have on the cancer community. #ASCO25 #Leadership
Exai Bio presented new data demonstrating the power of its RNA and AI based liquid biopsy platform to detect colorectal cancer. Stage I sensitivity in an independent cohort was 80%, exceeding other blood based approaches. Thanks to Amir Momen-Roknabadi for representing Exai Bio at #AACR25!
April 30, 2025 at 4:37 PM
Exai Bio presented new data demonstrating the power of its RNA and AI based liquid biopsy platform to detect colorectal cancer. Stage I sensitivity in an independent cohort was 80%, exceeding other blood based approaches. Thanks to Amir Momen-Roknabadi for representing Exai Bio at #AACR25!
DYK almost half of all women have dense breast tissue which means they are at higher risk of developing breast cancer? Exai is joining My Density Matters to spread awareness that today is Find Out My Breast Density Day. Talk to your doctor if you have questions. #BreastDensity #EarlyDetection
February 19, 2025 at 4:17 PM
DYK almost half of all women have dense breast tissue which means they are at higher risk of developing breast cancer? Exai is joining My Density Matters to spread awareness that today is Find Out My Breast Density Day. Talk to your doctor if you have questions. #BreastDensity #EarlyDetection
Together we unite to fight cancer and inspire hope.
#WorldCancerDay #UnitedByUnique #EarlyDetection #BreastCancer
#WorldCancerDay #UnitedByUnique #EarlyDetection #BreastCancer
February 4, 2025 at 4:56 PM
Together we unite to fight cancer and inspire hope.
#WorldCancerDay #UnitedByUnique #EarlyDetection #BreastCancer
#WorldCancerDay #UnitedByUnique #EarlyDetection #BreastCancer
We are honored to welcome Karen E. Knudsen, MBA, PhD, to our board of directors. As an internationally recognized oncology leader and immediate past CEO of the American Cancer Society and its advocacy affiliate ACS CAN, Karen is deeply committed to ending cancer as we know it.
December 5, 2024 at 3:49 PM
We are honored to welcome Karen E. Knudsen, MBA, PhD, to our board of directors. As an internationally recognized oncology leader and immediate past CEO of the American Cancer Society and its advocacy affiliate ACS CAN, Karen is deeply committed to ending cancer as we know it.
Exai was proud to be part of the inaugural RISE UP For Breast Cancer Meeting hosted by UCSF. #breastcancer #womenshealth #UCSF
November 8, 2024 at 7:59 PM
Exai was proud to be part of the inaugural RISE UP For Breast Cancer Meeting hosted by UCSF. #breastcancer #womenshealth #UCSF
3 years of innovation never looked so sweet! Celebrating Exai’s 3rd anniversary today, one donut (and breakthrough) at a time! #lifeatexai
September 23, 2024 at 4:44 PM
3 years of innovation never looked so sweet! Celebrating Exai’s 3rd anniversary today, one donut (and breakthrough) at a time! #lifeatexai
Exai was proud to attend #ESMO2024, where we announced new data demonstrating the ability of our RNA liquid biopsy platform to determine breast cancer tumor ER and HER2 status. #liquidbiopsy #breastcancer
September 19, 2024 at 1:46 PM
Exai was proud to attend #ESMO2024, where we announced new data demonstrating the ability of our RNA liquid biopsy platform to determine breast cancer tumor ER and HER2 status. #liquidbiopsy #breastcancer
Join us at #ESMO2024 where Exai will present new data demonstrating the ability of our RNA liquid biopsy platform to determine breast cancer tumor ER and HER2 status. #liquidbiopsy #breastcancer
September 13, 2024 at 2:46 PM
Join us at #ESMO2024 where Exai will present new data demonstrating the ability of our RNA liquid biopsy platform to determine breast cancer tumor ER and HER2 status. #liquidbiopsy #breastcancer
We’re excited to announce Dave Daly has been appointed as Exai Bio’s CEO. Dave brings more than 30 years of extensive cancer diagnostics and executive leadership experience to lead the next chapter of Exai.
www.exai.bio/news/exai-bi...
www.exai.bio/news/exai-bi...
July 24, 2024 at 4:30 PM
We’re excited to announce Dave Daly has been appointed as Exai Bio’s CEO. Dave brings more than 30 years of extensive cancer diagnostics and executive leadership experience to lead the next chapter of Exai.
www.exai.bio/news/exai-bi...
www.exai.bio/news/exai-bi...
Exai celebrates diversity and wishes everyone a very happy Pride Month. #PrideMonth #earlydetection #lifeatexai #MRD
June 19, 2024 at 4:07 PM
Exai celebrates diversity and wishes everyone a very happy Pride Month. #PrideMonth #earlydetection #lifeatexai #MRD
Proud to present our latest RNA- and AI-based #liquidbiopsy research at #ASCO24! #earlydetection #lifeatexai #MRD
June 4, 2024 at 5:22 PM
Proud to present our latest RNA- and AI-based #liquidbiopsy research at #ASCO24! #earlydetection #lifeatexai #MRD
May 28, 2024 at 5:50 PM
The Exai team had a productive week at #AACR24! We were proud to showcase our #liquidbiopsy research in both early cancer detection and MRD. #earlydetection #lifeatexai #MRD
April 15, 2024 at 5:50 PM
The Exai team had a productive week at #AACR24! We were proud to showcase our #liquidbiopsy research in both early cancer detection and MRD. #earlydetection #lifeatexai #MRD
